Beijing Chunlizhengda Medical Instruments Valuation
Is 1858 undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score 2/6
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Below Fair Value
Significantly Below Fair Value
Key Valuation Metric
Which metric is best to use when looking at relative valuation for 1858?
Other financial metrics that can be useful for relative valuation.
|What is 1858's n/a Ratio?|
Price to Earnings Ratio vs Peers
How does 1858's PE Ratio compare to its peers?
|1858 PE Ratio vs Peers|
|Company||PE||Estimated Growth||Market Cap|
1302 LifeTech Scientific
1789 AK Medical Holdings
6699 Angelalign Technology
1696 Sisram Medical
1858 Beijing Chunlizhengda Medical Instruments
Price-To-Earnings vs Peers: 1858 is good value based on its Price-To-Earnings Ratio (13.1x) compared to the peer average (42.5x).
Price to Earnings Ratio vs Industry
How does 1858's PE Ratio compare vs other companies in the Asian Medical Equipment Industry?
Price-To-Earnings vs Industry: 1858 is good value based on its Price-To-Earnings Ratio (13.1x) compared to the Asian Medical Equipment industry average (19.4x)
Price to Earnings Ratio vs Fair Ratio
What is 1858's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
|Current PE Ratio||13.1x|
|Fair PE Ratio||n/a|
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate 1858's Price-To-Earnings Fair Ratio for valuation analysis.
Share Price vs Fair Value
What is the Fair Price of 1858 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: 1858 (HK$12.18) is trading above our estimate of fair value (HK$3.15)
Significantly Below Fair Value: 1858 is trading above our estimate of fair value.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.